JPMorgan Chase & Co’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $182K | Sell |
139,973
-271,638
| -66% | -$353K | ﹤0.01% | 4506 |
|
|
2025
Q1 | $572K | Buy |
411,611
+363,298
| +752% | +$505K | ﹤0.01% | 3931 |
|
|
2024
Q4 | $111K | Buy |
48,313
+36,093
| +295% | +$82.7K | ﹤0.01% | 4741 |
|
|
2024
Q3 | $33.2K | Buy |
12,220
+350
| +3% | +$952 | ﹤0.01% | 5098 |
|
|
2024
Q2 | $27.8K | Sell |
11,870
-2,827
| -19% | -$6.62K | ﹤0.01% | 5073 |
|
|
2024
Q1 | $68.9K | Sell |
14,697
-12
| -0.1% | -$56 | ﹤0.01% | 4859 |
|
|
2023
Q4 | $71.8K | Hold |
14,709
| – | – | ﹤0.01% | 4901 |
|
|
2023
Q3 | $68.4K | Buy |
14,709
+200
| +1% | +$930 | ﹤0.01% | 4799 |
|
|
2023
Q2 | $107K | Buy |
14,509
+2,415
| +20% | +$17.8K | ﹤0.01% | 4605 |
|
|
2023
Q1 | $99K | Buy |
12,094
+3,154
| +35% | +$25.8K | ﹤0.01% | 4656 |
|
|
2022
Q4 | $85K | Buy |
8,940
+323
| +4% | +$3.07K | ﹤0.01% | 4551 |
|
|
2022
Q3 | $101K | Buy |
8,617
+186
| +2% | +$2.18K | ﹤0.01% | 4461 |
|
|
2022
Q2 | $108K | Buy |
8,431
+2,138
| +34% | +$27.4K | ﹤0.01% | 4593 |
|
|
2022
Q1 | $69K | Buy |
6,293
+408
| +7% | +$4.47K | ﹤0.01% | 4886 |
|
|
2021
Q4 | $90K | Buy |
5,885
+2,953
| +101% | +$45.2K | ﹤0.01% | 4872 |
|
|
2021
Q3 | $41K | Sell |
2,932
-7,009
| -71% | -$98K | ﹤0.01% | 5002 |
|
|
2021
Q2 | $193K | Buy |
+9,941
| New | +$193K | ﹤0.01% | 4514 |
|